
May Conference Roundup: AXS24, Digestive Disease Week
Take a look back at the conference coverage you may have missed this month.
Digestive Disease Week
Digestive Disease Week 2024 was held May 18 to 21 in Washington, DC.
The significant association between immune response and administration of a standard or multi-dose hepatitis B vaccine was not noted in those with hepatitis C virus, according to researchers.
Semaglutide can help patients with metabolic dysfunction-associated steatotic liver disease (MASLD) lose weight and truncal fat while preserving skeletal muscle over the course of a year.
AXS24 Asembia Specialty Pharmacy Summit
The 2024 Asembia Specialty Pharmacy Summit was held April 30 to May 2 in Las Vegas, NV.
Lakesha Farmer, Senior Director, Strategic Accounts, ION Oncology Practice Network at Cencora, sat down with Drug Topics to discuss the biosimilar adoption, access, and pricing.
Natalie Bedford, Senior Vice President, US Pharmaceutical Distribution Services at McKesson, sat down with Drug Topics to discuss the growth of the specialty drug market and the ways McKesson is helping manufacturing partners navigate regulatory changes.
Fran Gregory, Vice President of Emerging Therapies at Cardinal Health, sat down with Drug Topics to discuss the role of pharmacists in improving biosimilar uptake and advocating for health system sustainability.
Corey Ford, Vice President of Reimbursement and Policy Insights at Cencora, sat down with Drug Topics to discuss the evolution of the Inflation Reduction Act and what stakeholders—from biopharma companies to payers—can expect in 2025 and beyond.
Don’t miss a minute of our conference coverage: Sign up for our
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































